Skip to main content
    O

    Ocular Therapeutix Inc (OCUL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.02
    +0.01 (+0.17%)

    Market Cap: $1.37B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Ocular Therapeutix Inc (OCUL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ocular Therapeutix (OCUL) has a latest price of $6.02 on Nov 17, 2026, 63.4% below its 52-week high of $16.44. Its price fell 46.7% over the past 12 months. The month-end price rose 23.1% over the 10 years through Oct 2026, a compound annual rate of 2.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $20.70 in Dec 2020 and its lowest $2.48 in Nov 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart OCUL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OCUL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 48.7%, and over 6 months it fell 24.7%. The month-end price rose 144.6% over the 3 years through Oct 2026, a compound annual rate of 34.7%.

    PeriodChange
    1 month-4.3%
    3 months-48.7%
    6 months-24.7%
    12 months-46.7%
    12 months, with dividends-46.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+144.6%+34.7%
    5 years+5.0%+1.0%
    10 years+23.1%+2.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 424.1%, and its weakest was 2021, when it fell 66.3%.

    YearCloseChange
    2026 through Oct 2026$6.97-42.6%
    2025$12.14+42.2%
    2024$8.54+91.5%
    2023$4.46+58.7%
    2022$2.81-59.7%
    2021$6.97-66.3%
    2020$20.70+424.1%
    2019$3.95-0.8%
    2018$3.98-10.6%
    2017$4.45-46.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.8% below its 50-day average of $7.79 and 32.2% below its 200-day average of $8.87.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.02
    52-week high$16.44-63.4%
    52-week low$5.94+1.3%
    50-day average$7.79-22.8%
    200-day average$8.87-32.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 62.7%.

    MeasureValue
    1-year beta1.43
    Largest fall, 1 year-62.7%
    Largest fall, 3 years-62.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About OCUL

    What is OCUL's 1-year price change?

    Ocular Therapeutix's price fell 46.7% over the past 12 months. With dividends included, the 12-month total return was -46.7%.

    What is OCUL's 5-year price change?

    Ocular Therapeutix's month-end price rose 5.0% over the 5 years through Oct 2026, a compound annual rate of 1.0%. These figures leave out dividends.

    What is OCUL's 52-week high and low?

    Ocular Therapeutix's 52-week high is $16.44 and its 52-week low is $5.94. Its latest price of $6.02 on Nov 17, 2026 is 63.4% below the high.

    What is OCUL's beta?

    Ocular Therapeutix's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 62.7%.

    Is the OCUL chart free?

    Yes. Advanced Charting for OCUL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.